Search research articles
Contact Us
Filters
Showing results (441-450 of 740) with videos related to
Page
of 74
Sort By:
Journal of Medical Virology
|
December 1, 1995
Use of polymerase chain reaction and quantitative antibody tests in children born to human immunodeficiency virus-1-infected mothers
M L Newell, C Loveday, D Dunn, et al.
Antimicrobial Agents and Chemotherapy
|
June 14, 2021
<i>In Vitro</i> Antibacterial Activity of Cefiderocol against Multidrug-Resistant Acinetobacter baumannii
Jacinda C Abdul-Mutakabbir, Logan Nguyen, Philip T Maassen, et al.
International Journal of Antimicrobial Agents
|
January 2, 2017
Polymyxin B in combination with meropenem against carbapenemase-producing Klebsiella pneumoniae: pharmacodynamics and morphological changes
Rajnikant Sharma, Saloni Patel, Cely Abboud, et al.
Cancer Treatment Reports
|
December 1, 1987
Multicenter study of trilostane: a new hormonal agent in advanced postmenopausal breast cancer
C J Williams, V Barley, G Blackledge, et al.
Infectious Diseases and Therapy
|
June 6, 2024
Co-resistance Among Escherichia coli and Klebsiella pneumoniae Urine Isolates from Female Outpatients with Presumed UTI: A Retrospective US Cohort Study
Keith S Kaye, Vikas Gupta, Aruni Mulgirigama, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 25, 2004
Risk factors for postoperative mediastinitis due to methicillin-resistant Staphylococcus aureus
E S Dodds Ashley, D N Carroll, J J Engemann, et al.
Antimicrobial Agents and Chemotherapy
|
April 26, 2017
Critical Need for Clarity in Polymyxin B Dosing
Nikolas J Onufrak, Gauri G Rao, Alan Forrest, et al.
Journal of the National Cancer Institute
|
May 3, 1995
Docetaxel: an active new drug for treatment of advanced epithelial ovarian cancer
M J Piccart, M Gore, W Ten Bokkel Huinink, et al.
European Journal of Cancer & Clinical Oncology
|
August 1, 1983
A randomised multicentre single blind comparison of a cannabinoid anti-emetic (levonantradol) with chlorpromazine in patients receiving their first cytotoxic chemotherapy
A W Hutcheon, J B Palmer, M Soukop, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
November 14, 2016
The Impact of Systemic Therapy Beyond First-line Treatment for Advanced Cervical Cancer
J McLachlan, S Boussios, A Okines, et al.
Page
of 74
Search research articles
Search
Showing results (441-450 of 740) with videos related to
Sort By:
Page
of 74
Journal of Medical Virology
|
December 1, 1995
Use of polymerase chain reaction and quantitative antibody tests in children born to human immunodeficiency virus-1-infected mothers
M L Newell, C Loveday, D Dunn, et al.
Antimicrobial Agents and Chemotherapy
|
June 14, 2021
<i>In Vitro</i> Antibacterial Activity of Cefiderocol against Multidrug-Resistant Acinetobacter baumannii
Jacinda C Abdul-Mutakabbir, Logan Nguyen, Philip T Maassen, et al.
International Journal of Antimicrobial Agents
|
January 2, 2017
Polymyxin B in combination with meropenem against carbapenemase-producing Klebsiella pneumoniae: pharmacodynamics and morphological changes
Rajnikant Sharma, Saloni Patel, Cely Abboud, et al.
Cancer Treatment Reports
|
December 1, 1987
Multicenter study of trilostane: a new hormonal agent in advanced postmenopausal breast cancer
C J Williams, V Barley, G Blackledge, et al.
Infectious Diseases and Therapy
|
June 6, 2024
Co-resistance Among Escherichia coli and Klebsiella pneumoniae Urine Isolates from Female Outpatients with Presumed UTI: A Retrospective US Cohort Study
Keith S Kaye, Vikas Gupta, Aruni Mulgirigama, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 25, 2004
Risk factors for postoperative mediastinitis due to methicillin-resistant Staphylococcus aureus
E S Dodds Ashley, D N Carroll, J J Engemann, et al.
Antimicrobial Agents and Chemotherapy
|
April 26, 2017
Critical Need for Clarity in Polymyxin B Dosing
Nikolas J Onufrak, Gauri G Rao, Alan Forrest, et al.
Journal of the National Cancer Institute
|
May 3, 1995
Docetaxel: an active new drug for treatment of advanced epithelial ovarian cancer
M J Piccart, M Gore, W Ten Bokkel Huinink, et al.
European Journal of Cancer & Clinical Oncology
|
August 1, 1983
A randomised multicentre single blind comparison of a cannabinoid anti-emetic (levonantradol) with chlorpromazine in patients receiving their first cytotoxic chemotherapy
A W Hutcheon, J B Palmer, M Soukop, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
November 14, 2016
The Impact of Systemic Therapy Beyond First-line Treatment for Advanced Cervical Cancer
J McLachlan, S Boussios, A Okines, et al.
Page
of 74